TIA
BMY icon

Tiemann Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Tiemann Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Buy
4,021
+225
+6% +$13.1K 0.1% 162
2025
Q4 		$205K Buy
+3,796
New +$183K 0.08% 190
2025
Q2 		– Sell
-4,031
Closed -$246K – 201
2025
Q1 		$246K Hold
4,031
– – 0.11% 157
2024
Q4 		$228K Sell
4,031
-40
-1% -$2.23K 0.1% 174
2024
Q3 		$211K Buy
+4,071
New +$191K 0.09% 187
2024
Q2 		– Sell
-4,271
Closed -$232K – 195
2024
Q1 		$232K Sell
4,271
-50
-1% -$2.55K 0.1% 172
2023
Q4 		$222K Sell
4,321
-125
-3% -$6.56K 0.11% 171
2023
Q3 		$258K Hold
4,446
– – 0.14% 147
2023
Q2 		$284K Sell
4,446
-35
-0.8% -$2.35K 0.14% 148
2023
Q1 		$311K Hold
4,481
– – 0.17% 131
2022
Q4 		$322K Buy
4,481
+250
+6% +$18.9K 0.19% 125
2022
Q3 		$301K Sell
4,231
-1,425
-25% -$103K 0.2% 116
2022
Q2 		$436K Sell
5,656
-10
-0.2% -$762 0.23% 93
2022
Q1 		$414K Sell
5,666
-240
-4% -$16.1K 0.19% 116
2021
Q4 		$368K Sell
5,906
-320
-5% -$18.8K 0.16% 147
2021
Q3 		$368K Sell
6,226
-300
-5% -$19.8K 0.17% 131
2021
Q2 		$436K Sell
6,526
-1,020
-14% -$66.5K 0.2% 115
2021
Q1 		$476K Sell
7,546
-1,217
-14% -$75.7K 0.24% 102
2020
Q4 		$544K Hold
8,763
– – 0.29% 84
2020
Q3 		$528K Buy
8,763
+100
+1% +$6.02K 0.33% 74
2020
Q2 		$509K Buy
8,663
+600
+7% +$35.9K 0.35% 70
2020
Q1 		$449K Sell
8,063
-432
-5% -$26.4K 0.39% 67
2019
Q4 		$545K Buy
8,495
+417
+5% +$23.9K 0.37% 69
2019
Q3 		$410K Buy
8,078
+650
+9% +$30.5K 0.3% 95
2019
Q2 		$337K Sell
7,428
-100
-1% -$4.66K 0.24% 120
2019
Q1 		$359K Hold
7,528
– – 0.27% 107
2018
Q4 		$391K Sell
7,528
-575
-7% -$30.9K 0.35% 83
2018
Q3 		$503K Sell
8,103
-1,025
-11% -$60.8K 0.38% 67
2018
Q2 		$505K Sell
9,128
-1,000
-10% -$54K 0.4% 69
2018
Q1 		$641K Hold
10,128
– – 0.52% 57
2017
Q4 		$621K Hold
10,128
– – 0.5% 60
2017
Q3 		$646K Hold
10,128
– – 0.55% 58
2017
Q2 		$564K Hold
10,128
– – 0.51% 61
2017
Q1 		$551K Sell
10,128
-1,425
-12% -$78.2K 0.51% 60
2016
Q4 		$675K Buy
11,553
+300
+3% +$16.4K 0.66% 49
2016
Q3 		$607K Hold
11,253
– – 0.56% 56
2016
Q2 		$828K Sell
11,253
-590
-5% -$41.7K 0.78% 37
2016
Q1 		$757K Hold
11,843
– – 0.75% 41
2015
Q4 		$815K Buy
11,843
+330
+3% +$21.8K 0.83% 35
2015
Q3 		$682K Sell
11,513
-545
-5% -$34.6K 0.75% 37
2015
Q2 		$802K Buy
12,058
+300
+3% +$19.8K 0.82% 36
2015
Q1 		$758K Hold
11,758
– – 0.79% 36
2014
Q4 		$694K Sell
11,758
-35
-0.3% -$1.97K 0.75% 37
2014
Q3 		$604K Sell
11,793
-375
-3% -$18.7K 0.67% 47
2014
Q2 		$590K Hold
12,168
– – 0.65% 50
2014
Q1 		$632K Hold
12,168
– – 0.71% 44
2013
Q4 		$647K Buy
+12,168
New +$620K 0.77% 39

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiemann Investment Advisors's BMY Position: Q1 2026 in Review

Tiemann Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.9% in Q1 2026, buying an estimated $13.1K and bringing the position to 4,021 shares worth $244K. The position accounts for 0.1% of the portfolio, ranked #162.

Tiemann Investment Advisors first reported a position in BMY in Q4 2013 and has held it in 47 quarters since. The position peaked at $828K in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tiemann Investment Advisors held 4,021 shares of Bristol-Myers Squibb worth $244K as of Q1 2026.
  • Tiemann Investment Advisors bought 225 Bristol-Myers Squibb shares in Q1 2026, an estimated $13.1K.
  • Bristol-Myers Squibb made up 0.1% of Tiemann Investment Advisors's portfolio in Q1 2026, its #162 holding.
  • Tiemann Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 47 quarters since.
  • Tiemann Investment Advisors's Bristol-Myers Squibb position peaked at $828K in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tiemann Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.